AUPH

MKT CAP:$2B

Aurinia Pharmaceuticals Inc

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$15.66+$0.31 (+2.02%)

Jun 8, 2026

52W High $16.4252W Low $7.47

Company Details

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an...

CEO

—

IPO Date

Jan 26, 1999

Website

www.auriniapharma.com

Key Metrics TTM

Revenue

$298M

+20.6% YoY

Net Income

$298M

EPS (Diluted)

Free Cash Flow

$166M

Revenue / Share

$2.17

Gross Margin

89.7%

Operating Margin

41.7%

Net Margin

100.0%

FCF Margin

55.5%

P/S

6.6x

P/E

6.6x

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

May 7, 2026

$78M+24.4%

FY 2025

Feb 26, 2026

$283M+20.4%

Q4 2025

Feb 26, 2026

$77M+28.8%

Q3 2025

Nov 4, 2025

$73M+8.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee